Specific features of incorporation of cereal foods in babies with atopic dermatitis

Abstract

The objective of the investigation was to study the efficiency of dietary therapy incorporating New Zealand goat's milk-based buckwheat Bibikasha in the diets of 55 breast-fed babies with mild and moderate atopic dermatitis. The babies' age was 5 to 6 months. Of them, 30 babies who were given buckwheat Bibikasha as the first additional food formed a study group. A comparison group consisted of 25 babies who had milk-free instant buckwheat porridge as the first additional food. Low-allergen diet was prescribed for breast-feeding mothers. Incorporation of 150-ml New Zealand goat's milk-based buckwheat Bibikasha as the first cereal food in the diet of babies with atopic dermatitis showed its good tolerability and favorable effect on the course of the disease. Thus, multimodality therapy for atopic dermatitis in combination with dietary incorporation of the Bibikasha results in not only short-term positive results (remission on day 12 after therapy initiation and 3,4-fold reduction in SCORAD scores), but also a long-term positive effect (3,3-fold prolongation of remission and 3-fold reduction in the number of recurrences), and decreased levels of total serum IgE and allergen-specific IgE against casein with a good rate of weight gain. The dietary substitution of milk-free instant porridges for the new class of goat's milk-based formulas (Bibikasha) for babies with atopic dermatitis can optimize their dietary therapy.